"Leading Eye care provider in the area providing state of the art care in ophthlamology and retina surgery"

During the past decade, Texoma Retina Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Texoma Retina Center" are "Diabetic Macular Edema" (1 trials), "Retina Vein Occlusion" (1 trials) and "Symptomatic Vitreomacular Adhesion" (1 trials). Many other conditions were trialed in "Texoma Retina Center" in a lesser frequency.

Most popular intervention types in "Texoma Retina Center" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "GB-102" (1 trials). Other intervention names were less common.

The vast majority of trials in "Texoma Retina Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Texoma Retina Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Texoma Retina Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Texoma Retina Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".